FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3107025010> ?p ?o ?g. }

• W3107025010 endingPage "e040371" @default.
• W3107025010 startingPage "e040371" @default.
• W3107025010 abstract "Introduction Neuromyelitis optica spectrum disorders (NMOSD) is an inflammatory and heterogeneous astrocyte disorder of the central nervous system with the characteristic of higher incidence in women and Asian people. Most patients with NMOSD have a course of recurrence and remission that is prone to cause paralysis and blindness. Several studies have confirmed the efficacy and promising prospect of mycophenolate mofetil (MMF) in the treatment of NMOSD. Yet its therapeutic effect and safety are controversial. Although there has been two published literature that is relevant to the topic of this study, both of them have certain defects, and they can only provide answers about the efficacy or safety of MMF in the treatment of NMOSD from partial perspectives or conclusions. This research aims to perform a direct and comprehensive systematic review and meta-analysis to evaluate MMF’s effectiveness and safety in treating NMOSD. Methods and analysis This systematic review will cover all comparative researches, from randomised controlled trials to cohort studies, and case–control study. A relevant literature search will be conducted in PubMed, Web of Science, EMBASE, the Cochrane Library, China National Knowledge Infrastructure, Wanfang Database, China Science and Technology Journal Database and Chinese Biomedical Literature Database from their inception to 31 June 2020. We will also search registers of clinical trials, potential grey literature and abstracts from conferences. There are no limits on language and publication status. The reporting quality and risk of bias will be assessed by two researchers independently. Expanded Disability Status Scales and annualised relapse rate will be evaluated as the primary outcome. The secondary outcomes will consist of the frequency and severity of adverse events, best-corrected visual acuity, relapse-free rate and time to the next attack. A meta-analysis will be performed using RevMan V.5.3 software provided by the Cochrane Collaboration and Stata V.12.0. Ethics and dissemination Because the data used for this systematic review will be exclusively extracted from published studies, ethical approval and informed consent of patients will not be required. The systematic review will be published in a peer-reviewed journal, presented at conferences and will be shared on social media platforms. PROSPERO registration number CRD42020164179." @default.
• W3107025010 created "2020-12-07" @default.
• W3107025010 creator A5000603795 @default.
• W3107025010 creator A5014591045 @default.
• W3107025010 creator A5023726088 @default.
• W3107025010 creator A5031142220 @default.
• W3107025010 creator A5034466116 @default.
• W3107025010 creator A5038229401 @default.
• W3107025010 creator A5054480777 @default.
• W3107025010 creator A5056221361 @default.
• W3107025010 creator A5073706747 @default.
• W3107025010 date "2020-11-01" @default.
• W3107025010 modified "2023-10-17" @default.
• W3107025010 title "Safety and efficacy of mycophenolate mofetil in treating neuromyelitis optica spectrum disorders: a protocol for systematic review and meta-analysis" @default.
• W3107025010 cites W1976554229 @default.
• W3107025010 cites W1977920771 @default.
• W3107025010 cites W1979423827 @default.
• W3107025010 cites W1995396038 @default.
• W3107025010 cites W2009114633 @default.
• W3107025010 cites W2023686387 @default.
• W3107025010 cites W2027592786 @default.
• W3107025010 cites W2038941725 @default.
• W3107025010 cites W2046068958 @default.
• W3107025010 cites W2050098695 @default.
• W3107025010 cites W2053472907 @default.
• W3107025010 cites W2069414099 @default.
• W3107025010 cites W2102228952 @default.
• W3107025010 cites W2107941546 @default.
• W3107025010 cites W2112165124 @default.
• W3107025010 cites W2129229339 @default.
• W3107025010 cites W2136132690 @default.
• W3107025010 cites W2139087743 @default.
• W3107025010 cites W2157823046 @default.
• W3107025010 cites W2161374186 @default.
• W3107025010 cites W2169205464 @default.
• W3107025010 cites W2290972543 @default.
• W3107025010 cites W2309910633 @default.
• W3107025010 cites W2412889446 @default.
• W3107025010 cites W2418688327 @default.
• W3107025010 cites W2444189513 @default.
• W3107025010 cites W2540565392 @default.
• W3107025010 cites W2619381843 @default.
• W3107025010 cites W2744340589 @default.
• W3107025010 cites W2768127260 @default.
• W3107025010 cites W2771335117 @default.
• W3107025010 cites W2778216211 @default.
• W3107025010 cites W2783428344 @default.
• W3107025010 cites W2801139582 @default.
• W3107025010 cites W2887689171 @default.
• W3107025010 cites W2903411434 @default.
• W3107025010 cites W2907468245 @default.
• W3107025010 cites W2939976904 @default.
• W3107025010 cites W2946292274 @default.
• W3107025010 cites W2968688277 @default.
• W3107025010 cites W2989992495 @default.
• W3107025010 cites W3012376934 @default.
• W3107025010 cites W4253961323 @default.
• W3107025010 doi "https://doi.org/10.1136/bmjopen-2020-040371" @default.
• W3107025010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7705552" @default.
• W3107025010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33257483" @default.
• W3107025010 hasPublicationYear "2020" @default.
• W3107025010 type Work @default.
• W3107025010 sameAs 3107025010 @default.
• W3107025010 citedByCount "2" @default.
• W3107025010 countsByYear W31070250102021 @default.
• W3107025010 countsByYear W31070250102022 @default.
• W3107025010 crossrefType "journal-article" @default.
• W3107025010 hasAuthorship W3107025010A5000603795 @default.
• W3107025010 hasAuthorship W3107025010A5014591045 @default.
• W3107025010 hasAuthorship W3107025010A5023726088 @default.
• W3107025010 hasAuthorship W3107025010A5031142220 @default.
• W3107025010 hasAuthorship W3107025010A5034466116 @default.
• W3107025010 hasAuthorship W3107025010A5038229401 @default.
• W3107025010 hasAuthorship W3107025010A5054480777 @default.
• W3107025010 hasAuthorship W3107025010A5056221361 @default.
• W3107025010 hasAuthorship W3107025010A5073706747 @default.
• W3107025010 hasBestOaLocation W31070250101 @default.
• W3107025010 hasConcept C118552586 @default.
• W3107025010 hasConcept C126322002 @default.
• W3107025010 hasConcept C142724271 @default.
• W3107025010 hasConcept C17744445 @default.
• W3107025010 hasConcept C177713679 @default.
• W3107025010 hasConcept C189708586 @default.
• W3107025010 hasConcept C197934379 @default.
• W3107025010 hasConcept C199539241 @default.
• W3107025010 hasConcept C204787440 @default.
• W3107025010 hasConcept C2776478404 @default.
• W3107025010 hasConcept C2776681478 @default.
• W3107025010 hasConcept C2777200579 @default.
• W3107025010 hasConcept C2779473830 @default.
• W3107025010 hasConcept C2780385302 @default.
• W3107025010 hasConcept C2780640218 @default.
• W3107025010 hasConcept C2781137167 @default.
• W3107025010 hasConcept C512399662 @default.
• W3107025010 hasConcept C535046627 @default.
• W3107025010 hasConcept C61904560 @default.
• W3107025010 hasConcept C71924100 @default.
• W3107025010 hasConcept C95190672 @default.

• next